Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, January 04, 2018
INC Research/inVentiv Health has changed its brand identity to Syneos Health effective January 4, 2018.
read more
Monday, November 28, 2022
Incannex Healthcare Limited has engaged multinational contract development and manufacturing organization (CDMO) Eurofins Scientific to manufacture Incannex’s two distinct medicated chewable products designed to treat nicotine and opioid addiction ...
read more
Wednesday, March 25, 2020
Inceptua and biopharmaceutical company Oxurion have announced a global license agreement for the commercialization of JETREA.
read more
Wednesday, December 11, 2019
Inceptua announced Stefan Fraenkel has been appointed CEO effective 1 January 2020.
read more
Monday, February 03, 2020
Inceptua Group has announced Philip Gregory has joined the company as Vice President, Head of Asia-Pacific, Clinical Trial Services.
read more
Tuesday, February 18, 2020
Inceptua Group announces Philip Gregory has joined Inceptua as Vice President, Head of Asia-Pacific, Clinical Trial Services.
read more
Wednesday, December 18, 2019
Inceptua has announced the appointment of Paul Wituschek as President North America effective 1 January, 2020.
read more
Monday, November 25, 2019
Inceptua Group and Bendalis GmbH have announced an exclusive clinical trial supply agreement for oncology generics.
read more
Friday, February 07, 2020
Inceptua and Portola have entered into an agreement whereby Inceptua will become Portola’s exclusive distribution partner for Ondexxya® in selected countries.
read more
Thursday, December 18, 2025
INCOG BioPharma Services announced another major expansion with an investment of approximately $200Min its manufacturing facility in Fishers, Indiana. This investment will significantly increase the company's injectable drug product manufacturing ...
read more
Wednesday, April 06, 2022
INCOG BioPharma Services, an Indiana-based contract development and manufacturing organization (CDMO) has completed the construction of its cleanroom production area within the new 90,000ft2 biopharma manufacturing site.
read more
INCOG BioPharma Services announced that its sterile injectable manufacturing facility has received approval from the FDA to produce a commercially approved drug product. The regulatory approval for its customer signifies a significant milestone for ...
read more
INCOG BioPharma Services has completed the construction of its Quality Control testing laboratories, as well as the technology transfer and scale-up suite, at its headquarters in Fishers, Indiana.
read more
Incyte and Syros Pharmaceuticals have entered into a target discovery, research collaboration and option agreement.
read more
Indegene announced the launch of Indegene Omnipresence during a joint interview at the 11th Digital Pharma East Conference in Philadelphia.
read more